Current research projects
In the past, our lab has developed affinity-based biomaterials for protein and cell delivery to large bone defects and the stroke-injured brain. Currently, we're using new techniques in protein engineering and computational modeling to design more effective biomaterials for protein delivery.
Current strategies for controlling protein delivery from biomaterials rely on natural protein-material interactions with limited tunability or the expression of challenging fusion proteins.
We are using a combination of computational protein modeling and display platforms to generate specific affinity interactions with proteins of interest, such that their local presentation and effect on different stages of tissue healing may be tuned with precision and flexibility.
This approach will enable the controlled delivery of multiple therapeutics from a single biomaterial delivery vehicle..
Stem cell transplantation can stimulate tissue repair through the secretion of pro-regenerative paracrine factors. Harnessing the regenerative and immunomodulatory potential of stem cells through their secretome represents a recent paradigm shift in the field of tissue engineering.
We are creating biomaterial delivery vehicles that facilitate both paracrine- and cell-based tissue repair strategies by (1) presenting biochemical cues that promote cell viability and encourage paracine factor secretion of stem cells, and (2) selectively sequestering paracrine factors in the injury micro-environment using affinity-based biomaterials.
We aim to prolong local presentation of secreted proteins beyond the initial period of transplanted cell survival and create a pro-regenerative environment within injury sites.s.
A major challenge in developing biomaterials for sustained protein delivery is the difficulty of recapitulating the dynamic cellular and molecular makeup of the injury environment in the lab.
Many biomaterials that provide sustained delivery in vitro exhibit rapid protein release in vivo due to cellular uptake, competitive protein binding, and changes in tissue diffusivity.
We are developing computational models that better capture the dynamic healing environment and can more accurately predict protein release in vivo, allowing us to design better biomaterials for in vivo protein delivery.
Funding Sources
We are grateful for funding from the Collins Medical Trust, OHSU Medical Research Foundation, Department of Defense, National Institutes of Health, National Science Foundation, and Wu Tsai Human Performance Alliance.
The Wu Tsai Human Perfomance Alliance
National Institutes of Health (NIH)
National Science Foundation (NSF)
The US Department of War
We are always looking for partnerships both within and outside of the university to amplify the impact of our research.
Featured Publications
2026
Phased affinity-controlled delivery of vascular endothelial growth factor, fibroblast growth factor-2, and platelet derived growth factor enhances in vitro angiogenesis
Journal of Controlled Release
2025
Hyaluronic Acid-Coated Melt Electrowritten Scaffolds Promote Myoblast Attachment, Alignment, and Differentiation
Cellular and Molecular Bioengineering
2024
Recombinant and Synthetic Affibodies Function Comparably for Modulating Protein Release
Cellular and Molecular Bioengineering